Crizotinib (Xalkori)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Crizotinib (Xalkori), covering 2024-07-16 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma [Phase 2, Phase 3]